Episode updated 11/2022. Orilissa is a new oral GnRh antagonist that is being prescribed to manage pain associated with endometriosis. Today we look at the data to see how effective it actually is at treating pain. We explore the data from the clinical trials on Orilissa, the data hidden in the supplemental appendix of the published research, and the conclusions on its effectiveness and safety by ICER, an independent research institute.

🔗RESOURCES🔗

For clickable links to the resources below, go to www.insixteenyears.com/episode31

🔗Orilissa

CONNECT WITH US! INSTAGRAM: @in16yearsofendo

WEBSITE AND RESOURCES: insixteenyears.com

LIKE OUR SHOW? Please rate it or leave a review!

SUPPORT US by buying us a coffee: https://ko-fi.com/insixteenyears